<VariationArchive RecordType="classified" VariationID="2583605" VariationName="NM_004360.5(CDH1):c.1222dup (p.Ala408fs)" VariationType="Duplication" Accession="VCV002583605" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-28" DateCreated="2023-10-21" MostRecentSubmission="2023-10-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2751176" VariationID="2583605">
      <GeneList>
        <Gene Symbol="CDH1" FullName="cadherin 1" GeneID="999" HGNC_ID="HGNC:1748" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="68737292" stop="68835537" display_start="68737292" display_stop="68835537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="68771194" stop="68869443" display_start="68771194" display_stop="68869443" Strand="+" />
          </Location>
          <OMIM>192090</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004360.5(CDH1):c.1222dup (p.Ala408fs)</Name>
      <CanonicalSPDI>NC_000016.10:68813396:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="68813396" stop="68813397" display_start="68813396" display_stop="68813397" variantLength="1" positionVCF="68813396" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="68847299" stop="68847300" display_start="68847299" display_stop="68847300" variantLength="1" positionVCF="68847299" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>A408fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.68813397dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.68813397dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.68847300dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.68847300dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008021.1" sequenceAccession="NG_008021" sequenceVersion="1" change="g.81106dup">
            <Expression>NG_008021.1:g.81106dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317185.2" sequenceAccession="NM_001317185" sequenceVersion="2" change="c.-394dup">
            <Expression>NM_001317185.2:c.-394dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317186.2" sequenceAccession="NM_001317186" sequenceVersion="2" change="c.-598dup">
            <Expression>NM_001317186.2:c.-598dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004360.5" sequenceAccession="NM_004360" sequenceVersion="5" change="c.1222dup" MANESelect="true">
            <Expression>NM_004360.5:c.1222dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004351.1" sequenceAccession="NP_004351" sequenceVersion="1" change="p.Ala408fs">
            <Expression>NP_004351.1:p.Ala408fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001317184.2" sequenceAccession="NM_001317184" sequenceVersion="2" change="c.1137+1134dup">
            <Expression>NM_001317184.2:c.1137+1134dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_301" sequenceAccession="LRG_301">
            <Expression>LRG_301:g.81106dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_301t1" sequenceAccession="LRG_301t1">
            <Expression>LRG_301t1:c.1222dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_301p1" sequenceAccession="LRG_301p1" change="p.Ala408Glyfs">
            <Expression>LRG_301p1:p.Ala408Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004360.5(CDH1):c.1222dup (p.Ala408fs) AND Hereditary diffuse gastric adenocarcinoma" Accession="RCV003334527" Version="2">
        <ClassifiedConditionList TraitSetID="3314">
          <ClassifiedCondition DB="MedGen" ID="C1708349">Hereditary diffuse gastric adenocarcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-21" MostRecentSubmission="2023-10-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3314" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1360" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary diffuse gastric cancer</ElementValue>
                <XRef ID="Hereditary+diffuse+gastric+cancer/8514" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary diffuse gastric adenocarcinoma</ElementValue>
                <XRef ID="MONDO:0007648" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HDGC</ElementValue>
                <XRef Type="MIM" ID="137215" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (linitis plastica) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or isolated cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a CDH1 pathogenic variant occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer.</Attribute>
                <XRef ID="NBK1139" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10900" />
                <XRef ID="10900" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301318</ID>
                <ID Source="BookShelf">NBK1139</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACS, 2007">
                <ID Source="PubMed">17392385</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2010">
                <ID Source="pmc">2991043</ID>
              </Citation>
              <Citation Type="general" Abbrev="Klujit et al., 2012">
                <ID Source="PubMed">22388873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="IGCLC, 2020">
                <ID Source="PubMed">32758476</ID>
                <ID Source="pmc">7116190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Gastric Cancer, 2023</CitationText>
              </Citation>
              <XRef ID="26106" DB="Orphanet" />
              <XRef ID="C1708349" DB="MedGen" />
              <XRef ID="MONDO:0007648" DB="MONDO" />
              <XRef Type="MIM" ID="137215" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7567520" SubmissionDate="2023-10-23" DateLastUpdated="2023-10-28" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="102373429|OMIM:137215" />
        <ClinVarAccession Accession="SCV004042942" DateUpdated="2023-10-28" DateCreated="2023-10-21" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" OrgAbbreviation="MGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="16" alternateAllele="GG" referenceAllele="G" start="68847300" stop="68847300" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102373429</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="137215" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13911051</SubmissionName>
          <SubmissionName>SUB13922314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7567520" TraitType="Disease" MappingType="XRef" MappingValue="137215" MappingRef="OMIM">
        <MedGen CUI="C1708349" Name="Hereditary diffuse gastric adenocarcinoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

